Use of antipsychotic medications among elderly residents in long-term institutional care: A three-year follow-up

International Journal of Geriatric Psychiatry

Volumn 21, Issue 3, 2006, Pages 288-295

  Alanen, Hanna Mari ^a   Finne Soveri, Harriet ^b   Noro, Anja ^b   Leinonen, Esa ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Elderly residents; Long term institutional care; Minimum data set; Use of antipsychotics

Indexed keywords

ANXIOLYTIC AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT;

AGED; ARTICLE; BEHAVIOR DISORDER; CLINICAL ASSESSMENT; CONTROLLED STUDY; DATA BASE; FEMALE; FINLAND; FOLLOW UP; GERIATRIC CARE; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HUMAN; INSTITUTIONAL CARE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREVALENCE; RESIDENTIAL HOME; RETROSPECTIVE STUDY; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DRUG UTILIZATION; EPIDEMIOLOGIC METHODS; FEMALE; FINLAND; GERIATRIC ASSESSMENT; HOMES FOR THE AGED; HUMANS; LONG-TERM CARE; MALE; MENTAL DISORDERS; NURSING HOMES; SEX FACTORS;

EID: 33645576780     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1462     Document Type: Article

References (63)

1. Alexopoulos GS, Streim JE, Carpenter D, Docherty JP. 2004. Expert consensus panel for using antipsychotic drugs in older patients. J Clin Psychiatry 65(Suppl. 2): 5-99.
2. Alexopoulos GS. 2005. Mood disorders. In Kaplan & Sadock's Comprehensive Textbook of Psychiatry, 8th Edn, Sadoc BJ, Sadoc VA (eds). Lippincott Williams & Wilkins: Philadelphia; 3677-3686.
3. Ballard C, O'Brien J, James I, et al. 2001. Quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills, and psychotropic drugs. Int Psychogeriatr 13(1): 93-106.
4. Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG. 2000. Delusion and hallucinations in Alzheimer's disease: prevalence and clinical correlates. Int J Geriatr Psychiatry 15: 99-107.
5. Bernabei R, Murphy K, Frijters D, DuPaquier JN, Gardent H. 1997. Variation in training programmes for Resident Assessment Instrument implementation. Age Ageing 26: S31-S35.
6. Björkgren MA, Häkkinen U, Finne-Soveri UH, Fries BE. 1999. Validity and reliability of Resourse Utilization Groups (RUG-III) in Finnish long-term care facilities. Scand J Public Health 27: 228-234.
7. Brodaty H, Draper B, Saab D, et al. 2001. Psychosis, depression and bevioutal disturbances in Sydney nursing home residents: prevalence and predictors. Int J Geriatr Psychiatry 16: 504-512.
8. Bronskill SE, Anderson GM, Sykora K, et al. 2004. Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose, and specialist contact. J Am Geriatr Soc 52: 749-755.
9. Burrows AB, Morris JN, Simon SE, Hirdes J, Phillips CD. 2000. Development of an MDS-base Depression Rating Scale for use in nursing homes. Age Ageing 29: 165-172.
10. Carpenter GI, Gill S, Patter JM, Maxwell C. 1999. A comparison of MDS/RAI activity of daily living, cognitive performance and depression scales widely used scales. Age Aging 28(S2): 29.
11. Cooper B. 1990. Epidemiology and prevention in the mental health field. Soc Psychiatr Epidemiol 25(1): 9-15.
12. Coryell W, Pfohl B, Zimmerman M. 1984. The clinical and neuroendocrine features of psychotic depression. J Nervous Mental Dis 172: 521-528.
13. Doody RS, Stevens JC, Beck C, et al. 2001. Practice parameter: management of dementia (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 56: 1154-1166.
14. Eastley R, Wilcock GK. 1997. Prevalence and correlates of aggressive bahaviours occuring in patients with Alzheimer's disease. Int J Geriatr Psychiatry 12: 484-487.
15. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-mental state'. A practical method for grading the cognitive state of patients for clinician. J Psyc Res 12: 189-198.
16. Furniss L, Craig SKL, Burns A. 1998. Medication use in nursing homes for elderly people. Int J Geriatr Psychiatry 13: 433-439.
17. Gormley N, Rizwan MR. 1998. Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease. Int J Geriatr Psychiatry 13: 410-414.
18. Gormley N, Howard R. 1999. Should neuroleptics be used in the management of nursing home residents with dementia? Int J Geriatr Psychiatry 14: 509-511.
19. Gurwitz JH, Field TS, Avorn J, et al. 2000. Incidence and preventability of adverse drug events in nursing homes. Am J Med 109: 87-94.
20. Hartmaier SL, Sloane PD, Guess HA, Koch GG, Mitchell M, Phillips HA. 1995. Validation of the Minimum Data Set cognitive performance scale: agreement with the mini-mental state examination. J Gerontol Med Sci 50: M128-M133.
21. Hawes C, Morris JN, Phillips CD, Mor V, Fries BE, Nonemaker S. 1995. Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS). Gerontologist 35(2): 172-178.
22. Holmes C, Smith H, Ganderton R, et al. 2001. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. J Neurol Neurosurg Psychiatry 71: 777-779.
23. Holmquist I-B, Svensson B, Höglund P. 2003. Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol 59: 669-676.
24. Hughes CM, Lapane KL, Mor V, et al. 2000. The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. J Am Geriatr Soc 48: 931-937.
25. Häkkinen U, Rosenqvist G, Aro S. 1996. Economic depression and the use of physician services in Finland. Health Econ 5: 421-434.
26. Häkkinen U. 2002. Change in determinants of use of physician services in Finland between 1987 and 1996. Soc Sci Med 55: 1523-1537.
27. Junginger J, Phelan E, Cherry K, Levy J. 1993. Prevalence of psychopathology in elderly persons in nursing homes and in the community. Hosp Comm Psychiatry 44: 381-383.
28. Kindermann SS, Dolder CR, Bailey A, Katz IR, Jeste DV. 2002. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience. Drugs Aging 19(4): 257-276.
29. Klein DA, Steinberg M, Galik E, et al. 1999. Wandering behaviour in community-residing persons with dementia. Int J Geriatr Psychiatry 14: 272-279.
30. Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivelä S-L, Isoaho R. 2002. A model to classify the sedative load of drugs. Int J Geriatr Psychiatry 17: 874-883.
31. Lindesay J, Matthews R, Jagger C. 2003. Factors associated with antipsychotic drug use in residential care: changes between 1990 and 1997. Int J Geriatr Psychiatry 18: 511-519.
32. Liperoti R, Mor V, Lapane KL, Pedone C, Gambassi G, Bernabei R. 2003. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry 64: 1106-1112.
33. Lyketsos CG, Steele C, Galik E, et al. 1999. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry 156: 66-71.
34. Macdonald AJD, Carpenter GI, Box O, Roberts A, Sahu S. 2002. Dementia and use of psychotropic medication in non-'Elderly Mentally Infirm' nursing homes in South East England. Age Ageing 31: 58-64.
35. Maixner SM, Mellow AM, Tandon R. 1999. The efficacy, safety, and tolerability of antipsychotics in the elderly. J Clin Psychiatry 60: 29-41.
36. Morris JN, Fries BE, Mehr DR, et al. 1994. MDS Cognitive Performance Scale. J Gerontol 49(4): M174-M182.
37. Morris JN, Hawes C, Murphy K, Nonemaker S. 1995. Long Term Care Resident Assessment Instrument User's Manual Version 2.0. Health Care Financing Administration.
38. Morris JN, Fries BE, Morris SA. 1999. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci 54(11): M546-M533.
39. Morriss RK, Rovner BW, Folstein MF, German PS. 1990. Delusions in newly admitted residents of nursing homes. Am J Psychiatry 147: 299-302.
40. Myers JK, Weissman MM, Tisshler G. 1984. Six month prevalence of psychiatric disorders in three communities. Arch Gen Psychiatry 41: 959-970.
41. Noro A, Finne-Soveri H, Björkgren M, Vähäkangas P. 2005. Quality and productivity in institutional care for elderly residents - bencmarking with the RAI. National Research and Development Centre for Welfare and Health (STAKES), Helsinki.
42. Oborne CA, Hooper R, Li KC, Swift CG, Jackson SHD. 2002. An indicator of appropriate neuroleptic prescribing in nursing homes. Age Ageing 31: 435-439.
43. Ostling S, Skoog I. 2002. Psychotic symptoms and paranoid ideation in a nondemented population-based sample of the very old. Arch Gen Psychiatry 59: 53-59.
44. Ott BR, Tate CA, Gordon NM, Heindel WC. 1996. Gender differences in the behavioral manifestations of Alzheimer's disease. J Am Geriatr Soc 44: 583-587.
45. Ott BR, Lapane KL, Gambasse G. 2000. Gender differences in the treatment of behavior problems in Alzheimer's disease. Neurology 54: 427-432.
46. Phillips CD, Chu CW, Morris JN, Hawes C. 1993. Effects of cognitive impairment on the reliability of geriatric assessments in nursing homes. J Am Geriatr Soc 41: 136-142.
47. Pitkälä KH, Laurila JV, Strandberg TE, Tilvis RS. 2004. Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards. Int Psychogeriatr 16: 61-74.
48. Rovner BW, German PS, Broadhead J, Morris RK, Brant LJ, Folstein MF. 1990. The prevalence and management of dementia and other psychiatric disorders in nursing homes. Int Psychogeriatr 2: 13-24.
49. Rovner BW, Steele CD, German P, Clark R, Folstein MF. 1992. Psychiatric diagnosis and uncooperative behavior in nursing home. J Geriatr Psychiatry Neurol 5: 102-105.
50. Ruths S, Straand J, Nygaard HA. 2001. Psychotropic drug use in nursing homes - diagnostic indications and variations between institutions. Eur J Clin Pharmacol 57: 523-528.
51. Ryden MB. 1988. Aggressive behavior in persons with dementia who live in the community. Alzheimer Dis Assoc Disord 2: 342-355.
52. Sgadari A, Morris JN, Fries BE, et al. 1997. Efforts to establish the reliability of the Resident Assessment Instrument. Age Ageing 26: 27-30.
53. Shorr RI, Fought RL, Ray WA. 1994. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. J Am Med Assoc 271(5): 358-362.
54. Skoog I, Nilsson L, Landahl S, Steen B. 1993. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int Psychogeriatr 5: 33-48.
55. Snowdon J, Vaughan R, Miller R. Burgess EE, Tremlett P. 1995. Psychotropic drug use in Sydney nursing homes. Med J Assoc 163: 70-72.
56. Sorensen L, Foldspang A, Gulmann NC, Munk-Jorgensen P. 2001. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 16: 147-154.
57. Tariot PN, Podgorski CA, Blazina L, Leibovici A. 1993. Mental disorders in the nursing home: another perspective. Am J Psychiatry 150: 1063-1069.
58. Teri L, Borson S, Kiyak HA, Yamagishi M. 1989. Behavioral disturbance, cognitive dysfunction, and functional skill. J Am Geriatr Soc 37: 109-116.
59. Thakur M, Hays J, Krishnan KRR. 1999. Clinical, demographic and social characteristics of psychotic depression. Psychiatr Res 86: 99-106.
60. US Food and Drug Administration. 2005. Atypical Antipsychotic Drugs Information. Available at www.fda.gov/default.htm.
61. Vähäkangas P, Björkgren M. 2005. Quality and productivity in institutional care for elderly residents - bencmarking with the RAI. National Research and Development Centre for Welfare and Health (STAKES), Helsinki; 35-38.
62. Wilson RS, Gilley DW, Bennet DA, Beckett LA, Evans DA. 2000. Hallucinations, delusions, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 69: 172-177.
63. Wragg RE, Jeste DV. 1989. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 146: 577-587.